Chronic Myeloid Leukemia Treatments

This cluster of papers focuses on the efficacy and resistance of various tyrosine kinase inhibitors, such as Imatinib, Dasatinib, and Nilotinib, in the treatment of Chronic Myeloid Leukemia (CML). The papers discuss molecular mechanisms of resistance, mutation analysis, leukemia stem cells, treatment discontinuation, and long-term outcomes of different targeted therapies.

Journals publishing in this area

1

Blood

ISSN 0006-497118,388 articles in this topic

636h-index

0.98Impact

197.5KArticles

5.6MCitations

2

Leukemia

ISSN 0887-69242,014 articles in this topic

256h-index

5.60Impact

11.6KArticles

622.2KCitations

3

British Journal of Haematology

ISSN 0007-10481,710 articles in this topic

261h-index

2.22Impact

29.8KArticles

981.5KCitations